530 related articles for article (PubMed ID: 29737913)
21. Mucosal barrier, bacteria and inflammatory bowel disease: possibilities for therapy.
Merga Y; Campbell BJ; Rhodes JM
Dig Dis; 2014; 32(4):475-83. PubMed ID: 24969297
[TBL] [Abstract][Full Text] [Related]
22. Intestinal oxidative damage in inflammatory bowel disease: semi-quantification, localization, and association with mucosal antioxidants.
Kruidenier L; Kuiper I; Lamers CB; Verspaget HW
J Pathol; 2003 Sep; 201(1):28-36. PubMed ID: 12950014
[TBL] [Abstract][Full Text] [Related]
23. [Epithelial cell in intestinal homeostasis and inflammatory bowel diseases].
Zouiten-Mekki L; Serghini M; Fekih M; Kallel L; Matri S; Ben Mustapha N; Boubaker J; Filali A
Med Sci (Paris); 2013 Dec; 29(12):1145-50. PubMed ID: 24356146
[TBL] [Abstract][Full Text] [Related]
24. Immunopathogenesis of inflammatory bowel disease and mechanisms of biological therapies.
Ahluwalia B; Moraes L; Magnusson MK; Öhman L
Scand J Gastroenterol; 2018 Apr; 53(4):379-389. PubMed ID: 29523023
[TBL] [Abstract][Full Text] [Related]
25. Periodontal and inflammatory bowel diseases: Is there evidence of complex pathogenic interactions?
Lira-Junior R; Figueredo CM
World J Gastroenterol; 2016 Sep; 22(35):7963-72. PubMed ID: 27672291
[TBL] [Abstract][Full Text] [Related]
26. Intestinal barrier dysfunction: implications for chronic inflammatory conditions of the bowel.
Miner-Williams WM; Moughan PJ
Nutr Res Rev; 2016 Jun; 29(1):40-59. PubMed ID: 27087106
[TBL] [Abstract][Full Text] [Related]
27. Mechanisms of diarrhea in the interleukin-2-deficient mouse model of colonic inflammation.
Barmeyer C; Harren M; Schmitz H; Heinzel-Pleines U; Mankertz J; Seidler U; Horak I; Wiedenmann B; Fromm M; Schulzke JD
Am J Physiol Gastrointest Liver Physiol; 2004 Feb; 286(2):G244-52. PubMed ID: 14715519
[TBL] [Abstract][Full Text] [Related]
28. Interplay of Immunity and Vitamin D: Interactions and Implications with Current IBD Therapy.
Abdo J; Rai V; Agrawal DK
Curr Med Chem; 2017; 24(9):852-867. PubMed ID: 27784213
[TBL] [Abstract][Full Text] [Related]
29. Contentious host-microbiota relationship in inflammatory bowel disease--can foes become friends again?
Satokari R
Scand J Gastroenterol; 2015 Jan; 50(1):34-42. PubMed ID: 25523554
[TBL] [Abstract][Full Text] [Related]
30. Rules of Engagement: Epithelial-Microbe Interactions and Inflammatory Bowel Disease.
Jergens AE; Parvinroo S; Kopper J; Wannemuehler MJ
Front Med (Lausanne); 2021; 8():669913. PubMed ID: 34513862
[TBL] [Abstract][Full Text] [Related]
31. Etiology and pathogenesis of inflammatory bowel disease.
Schmidt C; Stallmach A
Minerva Gastroenterol Dietol; 2005 Jun; 51(2):127-45. PubMed ID: 15990703
[TBL] [Abstract][Full Text] [Related]
32. Monogenic diseases associated with intestinal inflammation: implications for the understanding of inflammatory bowel disease.
Uhlig HH
Gut; 2013 Dec; 62(12):1795-805. PubMed ID: 24203055
[TBL] [Abstract][Full Text] [Related]
33. A galectin-specific signature in the gut delineates Crohn's disease and ulcerative colitis from other human inflammatory intestinal disorders.
Papa Gobbi R; De Francesco N; Bondar C; Muglia C; Chirdo F; Rumbo M; Rocca A; Toscano MA; Sambuelli A; Rabinovich GA; Docena GH
Biofactors; 2016; 42(1):93-105. PubMed ID: 26891020
[TBL] [Abstract][Full Text] [Related]
34. T cell activation causes diarrhea by increasing intestinal permeability and inhibiting epithelial Na+/K+-ATPase.
Musch MW; Clarke LL; Mamah D; Gawenis LR; Zhang Z; Ellsworth W; Shalowitz D; Mittal N; Efthimiou P; Alnadjim Z; Hurst SD; Chang EB; Barrett TA
J Clin Invest; 2002 Dec; 110(11):1739-47. PubMed ID: 12464679
[TBL] [Abstract][Full Text] [Related]
35. CD40 and CD86 upregulation with divergent CMRF44 expression on blood dendritic cells in inflammatory bowel diseases.
Vuckovic S; Florin TH; Khalil D; Zhang MF; Patel K; Hamilton I; Hart DN
Am J Gastroenterol; 2001 Oct; 96(10):2946-56. PubMed ID: 11693331
[TBL] [Abstract][Full Text] [Related]
36. Prevalence and factors associated with gluten sensitivity in inflammatory bowel disease.
Limketkai BN; Sepulveda R; Hing T; Shah ND; Choe M; Limsui D; Shah S
Scand J Gastroenterol; 2018 Feb; 53(2):147-151. PubMed ID: 29216767
[TBL] [Abstract][Full Text] [Related]
37. Vascular involvement in inflammatory bowel disease: pathogenesis and clinical aspects.
Papa A; Scaldaferri F; Danese S; Guglielmo S; Roberto I; Bonizzi M; Mocci G; Felice C; Ricci C; Andrisani G; Fedeli G; Gasbarrini G; Gasbarrini A
Dig Dis; 2008; 26(2):149-55. PubMed ID: 18431065
[TBL] [Abstract][Full Text] [Related]
38. Gastrointestinal motility and absorptive disorders in patients with inflammatory bowel diseases: Prevalence, diagnosis and treatment.
Barros LL; Farias AQ; Rezaie A
World J Gastroenterol; 2019 Aug; 25(31):4414-4426. PubMed ID: 31496621
[TBL] [Abstract][Full Text] [Related]
39. Circadian rhythm abnormalities - Association with the course of inflammatory bowel disease.
Sobolewska-Włodarczyk A; Włodarczyk M; Szemraj J; Stec-Michalska K; Fichna J; Wiśniewska-Jarosińska M
Pharmacol Rep; 2016 Aug; 68(4):847-51. PubMed ID: 27166084
[TBL] [Abstract][Full Text] [Related]
40. Etiopathogenesis of inflammatory bowel diseases.
Danese S; Fiocchi C
World J Gastroenterol; 2006 Aug; 12(30):4807-12. PubMed ID: 16937461
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
